Amedisys Inc's Customers Performance

Name: Amedisys Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

AMED

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


AMED's Source of Revenues		During the corresponding time, Amedisys Inc recorded a revenue increase by 5.19 % year on year, sequentially revenue grew by 4.55 %. While revenue at the Amedisys Inc's corporate clients • List of AMED Customers

for the same period Amedisys Inc recorded revenue increase by 5.19 % year on year, sequentially revenue grew by 4.55 %.

• List of AMED Customers

Amedisys Inc's Business Units


Home Health Medicare	0 %	of total Revenue
Home Health Non-Medicare - Episodic Based	0 %	of total Revenue
Home Health Non-Medicare - Non-Episodic Based	0 %	of total Revenue
Hospice Medicare	0 %	of total Revenue
Hospice Non-Medicare	0 %	of total Revenue
High Acuity Care	1.72 %	of total Revenue
Home Health	63.71 %	of total Revenue
Hospice	34.57 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Amedisys Inc's Comment on Sales, Marketing and Customers

News about Amedisys Inc Contracts

Testing the Waters Amedisys Inc. Selected for Innovative Medicare Dementia Care Model Amidst Mixed Stock Performance

In a significant development for the healthcare sector, Amedisys Inc. has been selected by the Centers for Medicare and Medicaid Services (CMS) to participate in an innovative new Medicare Dementia Care Model. This initiative aims to enhance care for patients living with dementia, a growing public health concern that currently affects millions of Americans.The selection underscores Amedisys commitment to providing high-quality healthcare services. The dementia care model is designed to improve patient outcomes by integrating more comprehensive care options and resources for patients and their families. If successful, this model could set a benchmark for dementia care across the nation, potentially positioni...

Amedisys Boosts Infection Diagnosis with Advanced Molecular Testing

In a groundbreaking move, Amedisys, Inc., a leading provider of home health, hospice, and high-acuity care, has joined forces with Patient Choice Laboratories to offer advanced molecular testing across its care centers nationwide. This collaboration aims to revolutionize infection diagnosis by utilizing cutting-edge technology to swiftly and accurately identify pathogens in urine, respiratory, and wound infections. Let us delve into the facts surrounding this innovative approach and assess its potential impact on Amedisys as a company.1. Swift and Precise Identification of Pathogens:By incorporating molecular testing into their infection diagnostic procedures, Amedisys ensures a more rapid and accurate ident...

AMED's Stock Performance relative to it's Customers

AMED's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Amedisys Inc	3,361.86	2,402.37	81.87	19,000
SUBTOTAL	0.00	0.00	0.00	-

Sources: Amedisys Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Amedisys Inc’s corporate clients.
For your research, we’ve provided 9 tables on Amedisys Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.